v3.24.3
Stock-Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Stock Option Activity
The following table summarizes stock option and SAR activity for the nine months ended September 30, 2024 (in thousands, except per share amounts and years):
Options OutstandingSARs Outstanding
Number of Awards
Weighted-Average Exercise Price Per Share
Weighted-Average
Remaining Contractual Life (years)
Aggregate Intrinsic Value
Number of Awards
Weighted-Average Exercise Price Per Share
Weighted-Average
Remaining Contractual Life (years)
Aggregate Intrinsic Value
Balance as of December 31, 2023278,470 $8.62 7.6$2,381,172 — $— 0.0$— 
Granted— —  51,458 50.71  
Exercised(44,188)6.11  — —  
Canceled and forfeited(925)5.76  (3,495)50.00  
Balance as of September 30, 2024233,357 $9.10 7.1$6,556,252 47,963 $50.76 35.0$— 
Vested and exercisable as of September 30, 2024130,807 $7.32 6.5$3,908,239 — $— 0.0$— 
Summary of RSU Activity
The following table summarizes the RSU and P-RSU activity for the nine months ended September 30, 2024 (in thousands, except per share amounts):
RSUs OutstandingWeighted Average Grant Date Fair Value per ShareP-RSUs OutstandingWeighted Average Grant Date Fair Value per Share
Unvested and outstanding as of December 31, 202382,262 $10.71 1,976 $15.39 
Granted17,722 30.04 3,746 21.20 
Vested(24,595)13.58 (2,991)18.68 
Canceled and forfeited(3,188)13.39 (499)10.43 
Adjustment for performance achievement(1)
— — (1,370)17.46 
Unvested and outstanding as of September 30, 202472,201 $14.36 862 $28.81 
(1) This amount represents the difference between the maximum number of shares that could have been issued under the grant and the actual number of shares earned based on final performance.
Summary of Stock-Based Compensation Expense
Total stock-based compensation expense was as follows (in thousands):
Three Months Ended
September 30,		Nine Months Ended
September 30,
2024202320242023
Cost of revenue$13,123 $7,814 $35,941 $24,995 
Sales and marketing50,698 39,290 141,168 116,956 
Research and development30,715 21,952 87,532 65,068 
General and administrative47,889 45,324 145,199 136,276 
Total stock-based compensation expense$142,425 $114,380 $409,840 $343,295